D62
Conditions
Interventions
Group 1: Anaemic patients (male hb <13g/dl, female hb < 12 g/dl) who underwent the first stage of a two stage revision of their hip or knee prosthesie and who received an intravenous iron supplementat
Sponsors
Orthopädische Klinik König-Ludwig-Haus
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Group 1 (intervention): - hip or knee prosthesis explanted and replaced by spacer, - scheduled for re-implantation, - intravenous iron administration during the interval after explantation and before re-implantation, - no clinical signs of persistent infection at the time point of iron administration Group 2 (historic control): - prosthesis explanted and replaced by spacer, - scheduled for re-implantation, matched pair for group 1 according to type of joint, age, ASA score, gender and severeness of anaemia at the time point of iron supplementation
Exclusion criteria
Exclusion criteria: Group 1: none. Group 2: intravenous iron administration, - persistent clinical signs of infection at the matched patient's time point of iron administration
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Transfusion of allogenic red blood cells during or shortly after the re-implantation of the prosthesis. | — |
Secondary
| Measure | Time frame |
|---|---|
| Occurrence of adverse events after iron administration; mobility and length of stay after second surgery. | — |
Countries
Germany
Contacts
Public ContactAxel Jakuscheit
Orthopädische Klinik König-Ludwig-Haus
Outcome results
None listed